Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
Home > Understanding Breast Cancer > Early Detection & Screening > Early Detection & Screening References

  


Early Detection & Screening References

  

  1. Pisano ED, Gatsonis C, Hendrick E, et al. for the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 353(17):1773-83, 2005.
  2. Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology. 244(3):708-17, 2007.
  3. Pisano ED, Hendrick RE, Yaffe MJ, et al. for the DMIST Investigators Group. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 246(2):376-83, 2008.
  4. Morton MJ, Whaley DH, Brandt KR, Amrami KK. Screening mammograms: interpretation with computer-aided detection--prospective evaluation. Radiology. 239(2):375-83, 2006.
  5. Gilbert FJ, Astley SM, Gillan MG, et al. for the CADET II Group. Single reading with computer-aided detection for screening mammography. N Engl J Med. 359(16):1675-84, 2008.
  6. Fenton JJ, Abraham L, Taplin SH, et al. for the Breast Cancer Surveillance Consortium. Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst. 103(15):1152-61, 2011.
  7. American Cancer Society. Can breast cancer be found early? http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-detection?rnav=cri, 2013.
  8. Schell MJ, Yankaskas BC, Ballard-Barbash R, et al. Evidence-based target recall rates for screening mammography. Radiology. 243(3):681-9, 2007.
  9. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology. 258(1):98-105, 2011.
  10. de Gelder R, Draisma G, Heijnsdijk EA, de Koning HJ. Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths. Br J Cancer. 104(7):1214-20, 2011.
  11. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. (1):CD001877, 2011.
  12. Sechopoulos I, Hendrick RE. Mammography and the risk of thyroid cancer. AJR Am J Roentgenol. 198(3):705-7, 2012.
  13. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures, 2013. American Cancer Society, 2013.
  14. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 119(14):2518-23, 2013.
  15. BI-RADSÒ - Mammography, Fourth Edition. American College of Radiology. Reston, VA. http://www.acr.org/Quality-Safety/Resources/BIRADS/Mammography, 2003.
  16. American Cancer Society. Mammogram reports – BI-RADS. http://www.cancer.org/Treatment/UnderstandingYourDiagnosis/ExamsandTestDescriptions/MammogramsandOtherBreastImagingProcedures/mammograms-and-other-breast-imaging-procedures-mammo-report, 2013.
  17. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 151(10):716-726, 2009.
  18. National Cancer Institute. Mammograms. http://www.cancer.gov/cancertopics/factsheet/detection/mammograms, 2012.
  19. American Cancer Society. American Cancer Society recommendations for early breast cancer detection in women without breast symptoms. http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/breast-cancer-early-detection-acs-recs, 2013.
  20. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Breast cancer screening and diagnosis, Version 1.2013, http://www.nccn.org, 2013.
  21. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 363(13):1203-10, 2010.
  22. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L for the U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 151(10):727-37, W237-42, 2009.
  23. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 117(4):714-22, 2011.
  24. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow B, for the Trial Management Group. Eff ect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 368(9552):2053-60, 2006.
  25. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst. 96(19):1432-40, 2004.
  26. Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 146(7):511-5, 2007.
  27. American Geriatrics Society. Breast cancer screening in older women. American Geriatrics Society Clinical Practice Committee. J Am Geriatr Soc. 48(7):842-4, 2000.
  28. Fletcher SW and Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 348: 1672-80, 2003.
  29. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 225(1):165-75, 2002.
  30. Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol. 184(2):428-32, 2005.
  31. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 338: 1089-96, 1998.
  32. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 155(8):481-92, 2011.
  33. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 19(10):1026-34, 2010.
  34. Rossouw JE, Anderson GL, Prentice RL, et al. for the Women's Health Initiative (WHI) Investigators Writing Group. Risk and benefits of estrogen plus progestin in health postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 288(3):321-33, 2002.
  35. U.S. Food and Drug Administration. Menopause and hormones. http://www.fda.gov/forconsumers/byaudience/forwomen/ucm118624.htm, 2012.
  36. Chlebowski RT, Hendrix SL, Langer RD, et al. for the Women's Health Initiative Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 289(24):3243-53, 2003.
  37. Chlebowski RT, Anderson G, Manson JE, et al. Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy. J Clin Oncol. 28(16):2690-7, 2010.
  38. McTiernan A, Martin CF, Peck JD, et al. for the Women's Health Initiative Mammogram Density Study Investigators. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst. 97(18):1366-76, 2005.
  39. Stefanick ML, Anderson GL, Margolis KL, et al. for the Women's Health Initiative Investigators. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 295(14):1647-57, 2006.
  40. McTiernan A, Chlebowski RT, Martin C, et al. for the Women's Health Initiative Investigators. Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol. 27(36):6135-43, 2009.
  41. Esserman L, Cowley H, Eberle C, et al. Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst. 94(5): 369-75, 2002.
  42. Barlow WE, Chi C, Carney PA, et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst. 96(24):1840-50, 2004.
  43. Miglioretti DL, Gard CC, Carney PA, et al. When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology. 253(3):632-40, 2009.
  44. Elmore JG, Jackson SL, Abraham L, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 253(3):641-51, 2009.
  45. Taplin S, Abraham L, Barlow WE, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 100(12):876-87, 2008.
  46. Feig SA. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am. 45(5):791–800, 2007.
  47. Gotzsche PC and Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 355: 129-34, 2000.
  48. Olsen O and Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 358: 1340-2, 2001.
  49. American Cancer Society. Cancer Facts & Figures, 2013. American Cancer Society, 2013.
  50. Morrow M and Harris JR. Chapter 26: Ductal carcinoma in situ and microinvasive carcinoma, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  51. Chiarelli AM, Majpruz V, Brown P, Thriault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 101(18):1236-43, 2009.
  52. Centers for Disease Control and Prevention. Cancer: Symptoms of breast cancer. Atlanta, GA, Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/breast/basic_info/symptoms.htm, 2012.
  53. National Cancer Institute. Fact sheet-Paget's disease of the breast. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/factsheet/Sites-Types/paget-breast, 2012.
  54. American Cancer Society. Breast cancer: early detection. Atlanta, GA, American Cancer Society, http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-signs-symptoms-br-ca, 2013.
  55. National Cancer Institute. Breast cancer treatment: general information about breast cancer. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/pdq/treatment/breast/Patient#Keypoint4, 2013.
  56. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer (review). Cochrane Database Syst Rev. Issue 3: CD003373, 2008.
  57. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 23(33):8469-76, 2005.
  58. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 148(9):671-9, 2008.
  59. Granader EJ, Dwamena B, Carlos RC. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach. Acad Radiol. 15(12):1590-5, 2008.
  60. Saslow D, Boetes C, Burke W, et al. for the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 57(2):75-89, 2007.
  61. Berg WA, Zhang Z, Lehrer D, et al. for the ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 307(13):1394-404, 2012.
  62. Wisinski KB and Gradishar WJ. Chapter 64: Male Breast Cancer. In Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 34thrd edition. Lippincott, Williams and Wilkins, 2010.
  63. American Society of Clinical Oncology. Breast cancer – male. http://www.cancer.net/cancer-types/breast-cancer-male/symptoms, 2010.
  64. National Cancer Institute. Male breast cancer treatment. http://www.cancer.gov/cancertopics/pdq/treatment/malebreast, 2012.
  65. National Cancer Institute. Genetics of breast and ovarian cancer (PDQ). http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional/page2, 2012.
  66. Isaacs C, Peshkin BN, Schwartz M. Chapter 19: Genetic Testing and Management of Patients with Hereditary Breast Cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition, Lippincott Williams & Wilkins, 2010.
  67. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 22(4):735-42, 2004.
  68. Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 99(23):1811-4, 2007.
  69. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 25(11):1329-33, 2007.
  70. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet. 60(5): 1079–1084, 1997.
  71. Orr N, Lemnrau A, Cooke R, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet. 44(11):1182-4, 2012.
  72. Lehman CD, Gatsonis C, Kuhl CK, et al. for the ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 356(13):1295-303, 2007.
  73. Bernard JR Jr, Vallow LA, DePeri ER, et al. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the Mayo Clinic in Florida experience. Breast J. 16(2):118-26, 2010.
  74. Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw. 8(10):1157-64, 2010.
  75. Gartlehner G, Thaler K, Chapman A, et al. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev. 4:CD009632, 2013.
  76. Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol. 20(3):734-42, 2010.
  77. Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 28(9):1450-7, 2010.
  78. Bernardi D, Ciatto S, Pellegrini M, et al. Application of breast tomosynthesis in screening: incremental effect on mammography acquisition and reading time. Br J Radiol. 85(1020):e1174-8, 2012.
  79. Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 267(1):47-56, 2013.
  80. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol. S1470-2045(13)70134-7, 2013.
  81. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 257(1):246-53, 2010.
  82. Yang WT. Emerging techniques and molecular imaging in breast cancer. Semin Ultrasound CT MR. 32(4):288-99, 2011.
  83. Schoder H, Gonen M. Screening for cancer with PET and PET/CT: Potential and limitations. J Nucl Med. 48(Suppl 1):4S-18S, 2007.
  84. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR Appropriateness Criteria Breast Cancer Screening. J Am Coll Radiol. 10(1):11-4, 2013..
  85. Freedman MT. Chapter 15. Imaging: new techniques, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  86. American College of Radiology. Breast imaging position statement, 2000. http://www.acr.org/, 2013.
  87. U.S. Food and Drug Administration (FDA). FDA Safety Communication: Breast cancer screening - Thermography is not an alternative to mammography. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257633.htm, 2011.
  88. Duric N, Boyd N, Littrup P, et al. Breast density measurements with ultrasound tomography: a comparison with film and digital mammography. Med Phys. 40(1):013501, 2013.
  89. Mack KP, Pavao J, Tabnak F, Knutson K, Kimerling R. Adherence to recent screening mammography among Latinas: findings from the California Women's Health Survey. J Womens Health (Larchmt). 18(3):347-54, 2009.
  90. Miranda PY, Tarraf W, Gonzlez HM. Breast cancer screening and ethnicity in the United States: implications for health disparities research. Breast Cancer Res Treat. 128(2):535-42, 2011.
  91. Watson-Johnson LC, DeGroff A, Steele CB, et al. Mammography adherence: a qualitative study. J Womens Health (Larchmt). 20(12):1887-94, 2011.
  92. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 61(6):409-18, 2011.
  93. American Cancer Society. Cancer Facts and Figures for African Americans 2013-2014. Atlanta, GA: American Cancer Society, 2013.
  94. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2009: Fast Stats. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2009_pops09/index.html, 2012.
  95. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 56(3):168-83, 2006.
  96. Battaglia TA, Santana MC, Bak S, et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer. 116(4):913-21, 2010.
  97. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 23(31):7836-41, 2005.
  98. Warner ET, Tamimi RM, Hughes ME, et al. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 136(3):813-21, 2012.
  99. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 20;24(9):1342-9, 2006.
  100. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer. 112(1):171-80, 2008.
  101. Centers for Disease Control and Prevention (CDC). Vital signs: racial disparities in breast cancer severity--United States, 2005-2009. MMWR Morb Mortal Wkly Rep. 61(45):922-6, 2012.
  102. Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics. 110:752-7, 2002.
  103. Anderson SE, Dallal GE, Must A. Relative weight and race influence average age at menarche: results from two nationally representative surveys of US girls studied 25 years apart. Pediatrics. 111:844-50, 2003.
  104. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 295(21):2492-502, 2006.
  105. Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer. 116(21):4926-32, 2010.
  106. Warner ET, Tamimi RM, Boggs DA, et al. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control. 24(4):731-9, 2013.
  107. Batina NG, Trentham-Dietz A, Gangnon RE, et al. Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat. 138(2):519-28, 2013.
  108. American Cancer Society. Breast Cancer Facts & Figures, 2011-2012. American Cancer Society, 2011.
  109. American Cancer Society. Cancer Facts & Figures for Hispanics/Latinos, 2012-2014. American Cancer Society, 2013.
  110. Miller BA, Chu KC, Hankey BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control. 19(3):227-56, 2008.
  111. Wingo PA, King J, Swan J, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 113(5 Suppl):1191-202, 2008.
  112. Yi M, Liu P, Li X, et al. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. 118(17):4117-25, 2012.
  113. Miller JW, King JB, Joseph DA and Richardson LC for the Centers for Disease Control and Prevention (CDC). Breast cancer screening among adult women--Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 61 Suppl:46-50, 2012.
  114. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 110(10):2119-52, 2007.
  115. Austin SB, Pazaris MJ, Nichols LP, Bowen D, Wei EK, Spiegelman D. An examination of sexual orientation group patterns in mammographic and colorectal screening in a cohort of U.S. women. Cancer Causes Control. 24(3):539-47, 2013.
  116. Roberts SJ, Patsdaughter CA, Grindel CG, Tarmina MS. Health related behaviors and cancer screening of lesbians: results of the Boston Lesbian Health Project II. Women Health. 39(4):41-55, 2004.
  117. Hart SL, Bowen DJ. Sexual orientation and intentions to obtain breast cancer screening. J Womens Health (Larchmt). 18(2):177-85, 2009.
  118. Altman B, Bernstein A. Disability and health in the United States, 20012005. Hyattsville, MD: National Center for Health Statistics. 2008.
  119. Mobley LR, Kuo TM, Clayton LJ, Evans WD. Mammography facilities are accessible, so why is utilization so low? Cancer Causes Control. 20(6):1017-28, 2009.
  120. Courtney-Long E, Armour B, Frammartino B, Miller J. Factors associated with self-reported mammography use for women with and women without a disability. J Womens Health (Larchmt). 20(9):1279-86, 2011.
  121. Yankaskas BC, Dickens P, Bowling JM, et al. Barriers to adherence to screening mammography among women with disabilities. Am J Public Health. 100(5):947-53, 2010.
  122. Barr JK, Giannotti TE, Van Hoof TJ, Mongoven J, Curry M. Understanding barriers to participation in mammography by women with disabilities. Am J Health Promot. 22(6):381-5, 2008.
  123. Clark MA, Rogers ML, Wen X, et al. Repeat mammography screening among unmarried women with and without a disability. Womens Health Issues. 19(6):415-24, 2009.
  124. Centers for Disease Control and Prevention. Women with disabilities. http://www.cdc.gov/ncbddd/women/default.htm, 2012.
  125. Alexandraki I, Mooradian AD. Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc. 102(3):206-18, 2010.
  126. Ballew C, Cummings SJ, Oreskovich J. Reported barriers to cancer screening: Montana Behavioral Risk Factor Surveillance System 2007. Am J Health Promot. 24(5):311-4, 2010.
  127. American Cancer Society. Cancer Facts and Figures 2014. Atlanta, GA: American Cancer Society, 2014.

Updated 05/14/14 

010673.gif 

Early Detection & Screening Home